ATE378595T1 - Beurteilungen und mittel auf populationsbasis zur bestimmung der rangfolge der relativen immunogenität von proteinen - Google Patents

Beurteilungen und mittel auf populationsbasis zur bestimmung der rangfolge der relativen immunogenität von proteinen

Info

Publication number
ATE378595T1
ATE378595T1 AT03719326T AT03719326T ATE378595T1 AT E378595 T1 ATE378595 T1 AT E378595T1 AT 03719326 T AT03719326 T AT 03719326T AT 03719326 T AT03719326 T AT 03719326T AT E378595 T1 ATE378595 T1 AT E378595T1
Authority
AT
Austria
Prior art keywords
proteins
present
provides means
ranking
population
Prior art date
Application number
AT03719326T
Other languages
German (de)
English (en)
Inventor
Fiona Harding
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int filed Critical Genencor Int
Application granted granted Critical
Publication of ATE378595T1 publication Critical patent/ATE378595T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
AT03719326T 2002-02-26 2003-02-26 Beurteilungen und mittel auf populationsbasis zur bestimmung der rangfolge der relativen immunogenität von proteinen ATE378595T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36005702P 2002-02-26 2002-02-26

Publications (1)

Publication Number Publication Date
ATE378595T1 true ATE378595T1 (de) 2007-11-15

Family

ID=27766181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03719326T ATE378595T1 (de) 2002-02-26 2003-02-26 Beurteilungen und mittel auf populationsbasis zur bestimmung der rangfolge der relativen immunogenität von proteinen

Country Status (13)

Country Link
US (1) US7879571B2 (fr)
EP (1) EP1483581B1 (fr)
JP (1) JP4430944B2 (fr)
CN (3) CN1639571B (fr)
AT (1) ATE378595T1 (fr)
AU (1) AU2003223197A1 (fr)
CA (1) CA2476790C (fr)
DE (1) DE60317478T2 (fr)
DK (1) DK1483581T3 (fr)
IL (1) IL163139A (fr)
MX (1) MXPA04007498A (fr)
NZ (1) NZ534198A (fr)
WO (1) WO2003073068A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005119259A2 (fr) * 2004-04-26 2005-12-15 Genencor International, Inc. Procedes de prediction fondes sur des populations pour des determinations de reponses immunitaires et procedes pour verifier des donnees de reponse immunologique
WO2006116292A2 (fr) * 2005-04-27 2006-11-02 Genencor International, Inc. Procedes de reduction de l'immunogenicite de cytokines et d'extraction de marqueurs
WO2007008951A1 (fr) * 2005-07-12 2007-01-18 Codon Devices, Inc. Compositions et methodes pour la conception de proteines non immunogenes
US8871722B2 (en) * 2005-12-06 2014-10-28 Danisco Us Inc. Perhydrolase epitopes
FR2940451B1 (fr) 2008-12-18 2014-09-12 Proteus Procede d'evaluation de l'immunogenicite des proteines
CN110846299B (zh) * 2019-11-22 2021-09-24 江南大学 一种前导肽突变体及其在角蛋白酶生产中的应用
CN114107266B (zh) * 2021-11-29 2023-11-14 青岛尚德生物技术有限公司 耐热性提高的蛋白酶突变体及其编码基因和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261868A (en) 1979-08-08 1981-04-14 Lever Brothers Company Stabilized enzymatic liquid detergent composition containing a polyalkanolamine and a boron compound
US4404128A (en) 1981-05-29 1983-09-13 The Procter & Gamble Company Enzyme detergent composition
JPS58144105A (ja) 1982-02-12 1983-08-27 Kurabo Ind Ltd スケ−ル除去獣毛繊維の製法
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5185258A (en) 1984-05-29 1993-02-09 Genencor International, Inc. Subtilisin mutants
US5204015A (en) 1984-05-29 1993-04-20 Genencor International, Inc. Subtilisin mutants
WO1988004935A1 (fr) 1986-12-31 1988-07-14 United States Of America, Represented By The Unite Procede de prediction de sites antigeniques reconnus par les lymphocytes t, par exemple pour la conception de vaccins
KR920008256B1 (ko) 1987-10-30 1992-09-25 엘에스아이 로직 코포레이션 반도체 장치 패키지의 제조방법 및 장치
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US5691147A (en) * 1994-06-02 1997-11-25 Mitotix, Inc. CDK4 binding assay
US5627025A (en) * 1994-08-12 1997-05-06 The Rockefeller University Method for the identification of compounds capable of abrogating human immunodeficiency virus (HIV) infection of dendritic cells and T-lymphocytes
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
US6110695A (en) 1997-12-02 2000-08-29 The Regents Of The University Of California Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
US6835550B1 (en) 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US6451316B1 (en) 1998-10-05 2002-09-17 University Of Conneticut Health Center Methods for generating antigen-reactive T cells in vitro
US6861234B1 (en) * 2000-04-28 2005-03-01 Mannkind Corporation Method of epitope discovery

Also Published As

Publication number Publication date
CN1639571B (zh) 2010-05-26
US7879571B2 (en) 2011-02-01
CN1639571A (zh) 2005-07-13
EP1483581B1 (fr) 2007-11-14
CA2476790A1 (fr) 2003-09-04
US20050158806A1 (en) 2005-07-21
WO2003073068A3 (fr) 2003-12-11
JP2005518224A (ja) 2005-06-23
CA2476790C (fr) 2014-07-08
DE60317478T2 (de) 2008-09-04
IL163139A (en) 2010-12-30
EP1483581A4 (fr) 2005-08-10
JP4430944B2 (ja) 2010-03-10
AU2003223197A1 (en) 2003-09-09
DK1483581T3 (da) 2008-03-17
DE60317478D1 (de) 2007-12-27
NZ534198A (en) 2005-11-25
EP1483581A2 (fr) 2004-12-08
CN1703511A (zh) 2005-11-30
MXPA04007498A (es) 2004-11-10
CN101575635A (zh) 2009-11-11
AU2003223197A8 (en) 2003-09-09
WO2003073068A2 (fr) 2003-09-04

Similar Documents

Publication Publication Date Title
ATE531382T1 (de) Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen
IL166531A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
ATE402188T1 (de) Bindungsproteine als biosensoren
WO2005021592A3 (fr) Augmentation de la demi-vie circulante de proteines de type interleukine 2
ATE405650T1 (de) Produktion von ganzen antikörpern in prokaryontischen zellen
BRPI0411784A (pt) anticorpos contra interleucina -22 e usos para os mesmos
DE50207852D1 (de) Verwendung von fettalkoholethoxylaten als penetrationsförderer
NO2017028I1 (no) eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
BR0011838A (pt) Elementos misturadores estáticos empilhados
BRPI0507118A (pt) polipeptìdeos de interferon humano modificado e seus usos
EA201000424A1 (ru) Антитела к il-23
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
ATE378595T1 (de) Beurteilungen und mittel auf populationsbasis zur bestimmung der rangfolge der relativen immunogenität von proteinen
DE60329747D1 (de) Vektoren mit beiden isoformen von beta-hexosaminidase
BRPI0514124A (pt) anticorpos monoclonais humanos contra a il-4 humana
WO2003072595A3 (fr) Methodes fondees sur l'oligomerisation de proteines de stress et produits associes
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
DE60335665D1 (de) Mittel zur förderung der hautkollagenproduktion
EA200501711A1 (ru) Семейство секретируемых белков
DE69734586D1 (de) Retinoid-metabolisierendes protein
ATE368687T1 (de) Thrombopoietinproteine mit verbesserten eigenschaften
ATE544856T1 (de) Peptid- und nukleotidsequenzen von anisakis spp. und ihre verwendung
WO2005119259A3 (fr) Procedes de prediction fondes sur des populations pour des determinations de reponses immunitaires et procedes pour verifier des donnees de reponse immunologique
ATE343633T1 (de) Allele formen von menschlichem stat3
BRPI0412243A (pt) uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties